The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results from the skin cancer cohorts from an ongoing phase 1/2 multicohort study of RP1, an enhanced potency oncolytic HSV, combined with nivolumab (IGNYTE).
 
Mohammed M. Milhem
Consulting or Advisory Role - Exicure
Research Funding - Amgen (Inst); E.R. Squibb Sons, LLC (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst)
 
Ari M. Vanderwalde
Employment - Caris Life Sciences
Consulting or Advisory Role - Bristol-Myers Squibb; Caris Life Sciences; Compugen; Concerto HealthAI; Elsevier; Inivata
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Caris Life Sciences (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Immunomedics/Gilead (Inst); Lilly (Inst); Merck (Inst); Millennium (Inst); Replimune (Inst)
 
Tawnya Lynn Bowles
No Relationships to Disclose
 
Joseph J. Sacco
Honoraria - Immunocore; Novartis; Pierre Fabre
Consulting or Advisory Role - BMS; Delcath Systems; Immunocore; Immunocore (Inst); MSD
Research Funding - AstraZeneca (Inst); BMS (Inst); Immunocore (Inst); Replimune (Inst)
Travel, Accommodations, Expenses - BMS; MSD
 
Jiaxin Niu
Consulting or Advisory Role - AstraZeneca; Beigene; Boehringer Ingelheim; Bristol Mers Squibb; Daiichi Sankyo; Exact Sciences; Immvira; Johnson & Johnson; Merck; Mirati Therapeutics; OncLive Clinical Congress Consultants; Takeda
 
Katy K. Tsai
Consulting or Advisory Role - Bristol-Myers Squibb; Regeneron
Research Funding - ABM (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Oncosec (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst)
 
Jason Alan Chesney
Research Funding - Amgen; Bristol-Myers Squibb; Iovance Biotherapeutics; Replimune
Patents, Royalties, Other Intellectual Property - University of Louisville US Patents
 
Bartosz Chmielowski
Consulting or Advisory Role - Genentech; IDEAYA Biosciences; Iovance Biotherapeutics; Nektar; Novartis; OncoSec; Sanofi
Research Funding - Advenchen Laboratories (Inst); Array BioPharma (Inst); Ascentage Pharma (Inst); Atreca (Inst); Biothera (Inst); Bristol-Myers Squibb (Inst); Compugen (Inst); Daiichi Sankyo (Inst); IDEAYA Biosciences (Inst); Idera (Inst); Immunocore (Inst); Infinity Pharmaceuticals (Inst); Instil Bio (Inst); Instil Bio (Inst); Iovance Biotherapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); Merck (Inst); Neon Therapeutics (Inst); Novartis (Inst); PACT Pharma (Inst); RAPT Therapeutics (Inst); Replimune (Inst); Rgenix (Inst); Tolero Pharmaceuticals (Inst); Xencor (Inst)
 
Adel Samson
Research Funding - Stratosvir; Transgene (Inst); Transgene (Inst)
 
Terence Duane Rhodes
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb
 
Gino Kim In
Honoraria - Array BioPharma/Pfizer; Bristol-Myers Squibb; regeneron
Consulting or Advisory Role - Bristol-Myers Squibb; Castle Biosciences; Novartis; Sanofi
Speakers' Bureau - Merck; Regeneron; Rockpointe CME; Targeted Oncology
Research Funding - Checkmate Pharmaceuticals (Inst); Idera (Inst); Instil Bio (Inst); Regeneron (Inst); Replimune (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Regeneron
 
Anna C. Pavlick
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Regeneron; Sanofi/Regeneron
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Merck (Inst); Regeneron (Inst); replimune (Inst); Seagen (Inst)
 
Trisha Michel Wise-Draper
Stock and Other Ownership Interests - High Enroll
Honoraria - Physicans' Education Resource
Consulting or Advisory Role - Caris Life Sciences; Exicure; Merck; Rakuten Medical; Shattuck Labs
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Caris Life Sciences; GlaxoSmithKline; GlaxoSmithKline; Janssen Oncology; Merck
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; bexion; Bristol-Myers Squibb; Caris Life Sciences; Caris Life Sciences; Lilly; Merck; Tesaro
 
Miguel F. Sanmamed
No Relationships to Disclose
 
Praveen Bommareddy
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Junhong Zhu
Employment - Replimune
Stock and Other Ownership Interests - Replimune
 
Robert S. Coffin
Employment - Replimune
Leadership - Replimune
Stock and Other Ownership Interests - Replimune
 
Kevin Joseph Harrington
Honoraria - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Codiak Biosciences (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Oncolys BioPharma (Inst); Pfizer (Inst); Replimune (Inst)
Consulting or Advisory Role - Arch Oncology (Inst); AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Inzen Therapeutics (Inst); Merck Serono (Inst); MSD (Inst); Oncolys BioPharma (Inst); Replimune (Inst)
Speakers' Bureau - BMS (Inst); Merck Serono (Inst); MSD (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Merck Sharp & Dohme (Inst); Replimune (Inst)
 
Mark R. Middleton
Consulting or Advisory Role - Alkermes; Bayer; BiolineRx; Boehringer Ingelheim; Bristol-Myers Squibb; Immunocore; Kineta; Merck; Silicon Therapeutics; Vaccitech
Research Funding - Amgen (Inst); AstraZeneca (Inst); BiolineRx (Inst); Bristol-Myers Squibb (Inst); GRAIL (Inst); Immunocore (Inst); Medivir (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Regeneron (Inst); Replimune (Inst); Roche (Inst); Salvarx (Inst); Vaccitech (Inst)
(OPTIONAL) Uncompensated Relationships - GenesisCare